Stock & Company Details
Gyre Therapeutics Inc $GYRE
Price:
N/A
N/A
112M
$752M
52 Week High:
N/A
10 Day Average Volume:
N/A
-85.35
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GYRE technical indicators
Latest Gyre Therapeutics Inc (GYRE) indicator readings as of 2026-10-29.
GYRE's 14-day RSI is 47.3, in neutral territory. At $6.41 it is trading 8.5% below its 200-day moving average of $7.00, and below its 50-day average of $6.78. Price sits in the middle of its Bollinger Bands ($5.60 to $7.48). ADX reads 23.2, sitting between trending and range-bound.
Overview
catalyst is focused on developing novel medicines to address serious medical conditions for patients who need new or better treatment options. we used a scientific approach focused on protease-based therapeutic candidates to build a clinical-stage biopharmaceutical company whose current mission is to develop valuable therapies for patients with hemophilia. learn more about our hemophilia program. a protease is an enzyme that cleaves target proteins. learn more about proteases.
Finance Bot
Ask your questions
Start by typing a question below.
